Pietro Bersani - Oct 5, 2023 Form 4 Insider Report for Kiromic Biopharma, Inc. (KRBP)

Role
CEO, Director
Signature
/s/ Pietro Bersani
Stock symbol
KRBP
Transactions as of
Oct 5, 2023
Transactions value $
$0
Form type
4
Date filed
10/6/2023, 04:08 PM
Previous filing
Aug 15, 2022
Next filing
May 7, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRBP Restricted Stock Units Award $0 +65.6K $0.00 65.6K Oct 5, 2023 Common Stock 65.6K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. 49,200 of the RSUs vest upon date of grant, 5,467 vest on October 31, 2023, 5,467 vest on November 30, 2023 and 5,466 vest on December 31, 2023 provided that the Reporting Person remains in continuous service on each vesting date.